Glenmark Glenmark may be poised to release India’s first novel drug, from the in-licensed, anti-diarrheal molecule Crofelemer. Crofelemer has successfully complete Phase III trials, and you are readying to release it across 140 countries. What stage of the process are you in? When will we see India’s first novel drug in…
OctoPlus N.V. Clearly the end of 2010 was an exciting time for you. As you entered the transition period as the new CEO of OctoPlus, you also participated in the equity raising. In your view, what makes OctoPlus stand out in the market? There are two main components, one being the people…
As the founder of the Institute of Young Entrepreneurs at the Delft University of Technology and an enthusiastic promoter of innovation and new technologies, what do you believe distinguishes a successful entrepreneur from those that are bound to fail? A successful entrepreneur earns money. He is capable of shaping his…
Apotex Nederland BV We do not often meet companies that have been successful at retaining their manufacturing facilities in the Netherlands. How and why did former Katwijk Farma -and now Apotex- succeed to do so? Katwijk Farma’s history goes back to 1914 and was traditionally a family-owned company. Yet, in the nineties it…
Pfizer Nehterlands Pfizer is well placed for the next generation of growth. Coming off great M&A’s and now restructuring internally, (from the country structure to the business units). After closing 2010, the first full year since changes have been incorporated, what have been the effects here for the Dutch affiliate? How has…
Utrecht Science Park (USP) Certain cities have specific institutions, foundations, or in this case, science parks that serve as a microcosm for that city. How does Utrecht Science Park embody the identity and strengths of the city of Utrecht? This science park has two focuses: life sciences and sustainability, which particularly focuses on climate…
CRC - Center for Clinical Research Malaysia has good ethnic diversity, cost-effective infrastructure, and highly qualified principal investigators (PIs) and these elements have been in place for a long time. Why is now is the right time for a drive forward in clinical trials? Dr. Goh Pik Pin (GPP): Malaysia does offer a strong base for…
KPMG Netherlands While doing our research we couldn’t help but notice that you are quite passionate about issues related to healthcare and an avid proponent of healthcare reform. In this vein, what would be the ideal situation for the national healthcare system of the Netherlands and how should the country get there?…
IMS Health Netherlands IMS Health sets itself apart because of its global reach, while mastering local expertise. Clearly, every market is one of a kind. What is so particular about the Dutch market? There are quite a few particularities. When we discuss the value of the pharmaceutical market in the Netherlands for example,…
Medical Delta As the chairman of a consortium that has been working towards both medical and technological progress in the region, how have you seen this progress taking place in the Netherlands in recent years? Can we speak of convergence? Medical Delta was founded by academic institutions with the mission to transfer…
Indian Drug Manufacturers' Association (IDMA) Since we last met in 2006, the Indian pharmaceutical industry has been doing very well indeed, as a very large number of drugs came off patent. This trend will continue in the coming years. Today this is a crucial moment for India: the industry is at a crossroad. How has…
See our Cookie Privacy Policy Here
